The importance of PACAP in relationship to circulatory dysfunction caused by long-standing diabetes does not seem to be solely limited to restoring microvasculature, as the combined vasodilatory effects together with the growth-inhbitory functions of the peptide can be extended to the circulatory system in general. This evidence concerns the gene ADCYAP1 and diabetes mellitus.